Cat#:RP-270AC;Product Name:Recombinant Human CD300c / LMIR2 Protein;Synonym:CD300C, CLM-6, CMRF35-A1, CMRF-35, CMRF35A, IGSF16;Description:Recombinant Human CD300C /CLM-6 /IGSF16 Protein (rh CD300C /CLM-6 /IGSF16) Gly 21 - Arg 183 was produced in HEK293 cells.;Source:HEK293;Predicted N Terminal:Recombinant Human CD300C /CLM-6 /IGSF16 Protein (rh CD300C /CLM-6 /IGSF16) Gly 21 - Arg 183 (Accession # AAH22279) was produced in HEK293 cells at ACROBiosystems.;Molecular Characterization:Recombinant Human CD300c / LMIR2 Protein rh CD300C /CLM-6 /IGSF16 is fused with polyhistidine tag at the C-terminus, and has a calculated MW of 18.7 kDa. The predicted N-terminus is Gly 21. DTT-reduced Protein migrates as 25-45 kDa in SDS-PAGE due to glycosylation.;Purity:Greater than 95% as determined by SDS-PAGE.;Endotoxin:< 1.0 EU per μg of recombinant human CD300c / LMIR2 protein by the LAL method.;Formulation:Recombinant human CD300c / LMIR2 protein was lyophilized from 0.22 μm filtered solution in PBS, pH7.4.;Stability:Recombinant human CD300c / LMIR2 protein was stable up to 1 year from date of receipt at -70℃;Storage:Store recombinant human CD300c / LMIR2 protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.;Usage:For Lab Research Use Only;